[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
African Pioneer Plc LSE:ASP London Ordinary Share IM00B8C0HK22 ORD NPV
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 3.75 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
3.50 4.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Mining 7
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 3.75 GBX

African Pioneer (ASP) Latest News

More African Pioneer News
African Pioneer Investors    African Pioneer Takeover Rumours

African Pioneer (ASP) Discussions and Chat

African Pioneer Forums and Chat

Date Time Title Posts
06/5/201611:05Steely Dan2
11/1/200919:01Ascribe .... new to AIM280
01/12/200721:29Ascribe...time to buy???-
11/5/200406:53Aspinalls - Shares 0.01p, Cash = 0.025p319
02/1/200309:52ASPINALLS, LOOKING GOOD FOR THE FUTURE2,813

Add a New Thread

African Pioneer (ASP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all African Pioneer trades in real-time

African Pioneer (ASP) Top Chat Posts

DateSubject
30/11/2021
08:20
African Pioneer Daily Update: African Pioneer Plc is listed in the Mining sector of the London Stock Exchange with ticker ASP. The last closing price for African Pioneer was 3.75p.
African Pioneer Plc has a 4 week average price of 0p and a 12 week average price of 0p.
The 1 year high share price is 4.25p while the 1 year low share price is currently 3.75p.
There are currently 189,459,550 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of African Pioneer Plc is £7,104,733.13.
17/12/2008
09:22
ltinvestor: Having invested in this company 4 years before it came to AIM and at a period when it needed funds I feel very dissapointed that the directors are able to buy the company back for such a low price taking advantage of the present market climate for small stocks.
15/12/2008
11:51
chrisdgb: anyone else have an idea of the bid price??
12/12/2008
10:37
chrisdgb: price tightening...bid by Christmas..??? add to my Macro 4 present already...
12/11/2008
11:41
chrisdgb: ECI Ventures supposed to be exclusive on the bid, wonder what the price will be, 33p?????
01/10/2008
07:02
chrisdgb: nice looking results this morning, should move through the 30p.... apparently management think company is worth 60p per share....
19/8/2008
16:49
ltinvestor: Any guesses to buyout price?I am holding on as I expect the price to be higher than todays price.
24/6/2008
07:16
andy: http://www.proactiveinvestors.co.uk/articles/art.php?ASP
29/5/2008
23:00
backmarker: there was a reasonably positive article on ASP in SHARES mag. today. probably that which helped lift the share price
29/11/2007
12:56
currypasty: RNS Number:7729I Ascribe plc 29 November 2007 Ascribe plc (the "Company") Director Shareholding in Company The Company was informed on 29 November 2007 that Ian Priestner and David Hughes, both directors of the Company have purchased ordinary shares of 1p each in the Company ("Ordinary Shares"). Ian Priestner purchased 29,972 Ordinary Shares at a price of 33p per share on 28 November 2007. Mr Priestner's interest following this purchase stands at 29,972 Ordinary Shares, which represents 0.026 per cent. of the Company's current issued share capital. David Hughes purchased 65,000 Ordinary Shares at prices between 30 and 30.5p on 28 and 29 November 2007. Mr Hughes's interest following this purchase stands at 415,000 Ordinary Shares, which represents 0.353 per cent. of the Company's current issued share capital
22/10/2007
11:48
currypasty: RNS Number:1231G Ascribe plc 22 October 2007 Press Release 22 October 2007 Ascribe plc ("Ascribe" or "the Group") Ascribe plc acquires Scorpio Information Systems Limited enhancing portfolio of healthcare clinical information management systems 22 October 2007 - Ascribe plc (AIM:ASP), the health IT Group, today announces that it has acquired Scorpio Information Systems Limited ("Scorpio"), a supplier of clinical information management systems to the UK National Health Service (" NHS"). Scorpio has developed over thirty clinical modules for hospital departments and patient care; these include endoscopy reporting, maternity, eye-unit casualty and oncology clinics, which are in use at twelve NHS hospitals. This acquisition enables Ascribe to expand its Group offering with a greater range of comprehensive patient-centric information management systems, all of which are capable of securely feeding information into patients' electronic health records. The Ascribe Board expects to cross-sell Scorpio's systems to other customers of the Group. Scorpio will continue to develop clinician-focused modules that address the healthcare IT requirements of modern hospitals. Scorpio's solutions are underpinned by their ability to communicate health data efficiently and their faithful adherence to consistent best practice in a healthcare environment - from data collection through to the establishment of individual patient care pathways. The additional resources of the Ascribe group will enable Scorpio to extend its own suite of healthcare solutions. The total consideration of #1.31m, including payment for approximately #600k cash in Scorpio at completion, was satisfied by the payment of #0.88m cash and by the issue of ordinary shares in Ascribe plc to the value of #0.43m. In its last statutory accounts, Scorpio reported turnover of #0.52m and an operating profit of #0.24m. The Board believes that this acquisition will be earnings enhancing during the first year. Stephen Critchlow, Executive Chairman of Ascribe commented, "I am delighted with this acquisition; Ascribe and Scorpio share a fundamental approach towards product development. We have both focused our software on improving patient safety and supplying robust, integrated systems that quickly and easily deliver the decision critical information required by clinicians. Furthermore, having spent the 16 months since our last purchase developing an integrated business platform into which we can rapidly consolidate future acquisitions, we expect Scorpio to be both earnings enhancing and capable of stimulating further organic growth within a relatively short period."
African Pioneer share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
ASP
African Pi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211201 04:15:14